T1	Participants 73 110	infants younger than 6 months of age.
T2	Participants 280 306	children <6 months of age.
T3	Participants 631 699	administered intranasally to healthy children 6 to <24 weeks of age.
T4	Participants 708 763	Healthy infants aged 6 to <16 weeks and 16 to <24 weeks
